BMY / Bristol-Myers Squibb Company
as of 2026-03-07
Bias: MixedRisk: NormalMixed structure, RSI neutral, risk normal
Last
60.74
1D -2.55% • 5D -0.59% • 1M +8.48%
Updating…
Job #4644 • queued • 0/0 requests
Company
Bristol-Myers Squibb (BMY) is a leading biopharmaceutical firm dedicated to addressing serious medical conditions through innovative therapies. With a strong portfolio of medicines, the company emphasizes research and development to bring new treatments to market. BMY's focus spans various therapeutic areas, including oncology, immunology, and cardiovascular diseases, aiming to improve patient outcomes and quality of life. The company is also committed to sustainability and corporate responsibility, ensuring ethical practices in its operations.
Mini chart (last 120 D1 closes)
2025-10-10 → 2026-03-05
1D
-2.55%
5D
-0.59%
1M
+8.48%
Vol (20d)
27.4%
Weather meter
Δ +0
Overall60
Trend60
Volatility66
Sentiment50
Technicals
MA20
60.95
Below short-term trend
MA50
57.34
Above medium-term trend
MA200
—
RSI14
54.7
Neutral
What traders watch now
Support (MA50)
57.34
Resistance (MA200)
—
Key risk
Range / chop
Time horizon
2–10 trading days